Chest
Original ResearchIncidence of Chronic Thromboembolic Pulmonary Hypertension After a First Episode of Pulmonary Embolism
Section snippets
Patients
Consecutive patients who experienced a first episode of symptomatic, objectively confirmed PE, either idiopathic or associated with one or more temporary risk factors, were included in the study. For the purpose of this study, recent surgery, trauma with or without bone fracture, oral contraceptives, and prolonged bed rest were considered to be temporary risk factors for VTE. Initial PE was confirmed by pulmonary angiography, spiral CT scan, high-probability lung scan, or an
Materials and Methods
After the episode of acute PE, patients were evaluated every 3 months in the first year and then every 6 months for at least 3 years. In patients who presented with persistent dyspnea, either at rest or on exertion, a medical history was collected and a physical examination was performed to identify the potential causes of dyspnea. The presence of COPD, chronic heart failure, and interstitial lung diseases was confirmed by objective testing. All patients with persistent dyspnea underwent
Results
Overall, 259 patients were included in the study (145 were women; mean [± SD] age, 61 ± 16 years). PE was idiopathic or unprovoked in 135 patients, while in 124 patients it was associated with at least one temporary risk factor. Twenty patients (7.7%) received thrombolytic treatment in the acute phase of PE during the follow-up period. The average follow-up period was 46 months. Twenty-one patients died (8.1%) and 31 patients had a recurrence of VTE (12%), which was a second PE in 15 patients.
Discussion
After an average follow-up period of 46 months (minimum follow-up period, 3 years) of a cohort of patients with a first episode of acute PE, we observed an incidence of symptomatic CTPH of 0.8%. The incidence of symptomatic CTPH in patients with idiopathic PE was 1.5%. These incidences are consistent with those observed in previous studies.12 Furthermore, the 95% upper limit of the CI for the incidence of idiopathic CTPH after PE (3.6) is consistent with the incidence of 3.8% seen in the most
Appendix
Other investigators and sites involved in the study were as follows: Maddalena Miccio, MD, Unita Operativa Medicina d’Urgenza, Ospedale di Cattinara, Trieste, Italy; Davide Imberti, MD, Unita Operativa di Medicina Interna, Ospedale di Piacenza, Piacenza, Italy; Ferdinando Porro, MD, Medicina d’Urgenza, Ospedale Maggiore Policlinico, Milan, Italy; Adriano Bertoldi, MD, Divisione di Chirurgia Vascolare, Ospedale S. Chiara, Trento, Italy; Luigi Ria, MD, Emostasi ed Angiologia Medica, Ospedale
References (11)
- et al.
Long term follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data
Chest
(1982) - et al.
Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension
Chest
(1993) - et al.
Chronic major-vessel pulmonary hypertension
Circulation
(1990) - et al.
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism
N Engl J Med
(2004) - et al.
Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis
Eur Respir J
(2000)
Cited by (0)
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).
A list of other investigators and sites involved in the study is located in the Appendix.
None of the authors has any conflict of interest to disclose.
This study was performed without any external financial support.